Matches in Wikidata for { <http://www.wikidata.org/entity/Q92578912> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q92578912 description "2020 թվականի փետրվարի 11-ին հրատարակված գիտական հոդված" @default.
- Q92578912 description "article scientifique publié en 2020" @default.
- Q92578912 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q92578912 description "im Februar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92578912 description "scientific article published on 11 February 2020" @default.
- Q92578912 description "wetenschappelijk artikel" @default.
- Q92578912 description "наукова стаття, опублікована 11 лютого 2020" @default.
- Q92578912 name "Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analy" @default.
- Q92578912 name "Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analy" @default.
- Q92578912 type Item @default.
- Q92578912 label "Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analy" @default.
- Q92578912 label "Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analy" @default.
- Q92578912 prefLabel "Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analy" @default.
- Q92578912 prefLabel "Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analy" @default.
- Q92578912 P1433 Q92578912-8B31BA8A-B6E9-44EC-BDAC-84BEDB4FF593 @default.
- Q92578912 P1476 Q92578912-AB16FF52-9800-4AB4-A1A5-9CE0B0CF1DFB @default.
- Q92578912 P2093 Q92578912-05456E6D-7E6E-4710-A022-8F7144C781BB @default.
- Q92578912 P2093 Q92578912-20552A34-0507-453B-A508-1E458D4EC932 @default.
- Q92578912 P2093 Q92578912-93F9AFAE-A5C6-4B96-8182-7E6DBB2D1659 @default.
- Q92578912 P2093 Q92578912-9D61D8BB-E198-4277-8958-1E2C66176AAF @default.
- Q92578912 P2093 Q92578912-BBD6BBCF-236F-44E7-976E-C90FC191FEEE @default.
- Q92578912 P2093 Q92578912-F27D1B2D-CF8F-4BBC-BE12-DC12185EF810 @default.
- Q92578912 P304 Q92578912-5179A2C9-648E-41A2-A14B-805EE5A9F3A5 @default.
- Q92578912 P31 Q92578912-C181B25C-151C-485D-8399-5FE036610061 @default.
- Q92578912 P356 Q92578912-1163A854-7AA8-40F5-B0DC-A06B764639D8 @default.
- Q92578912 P433 Q92578912-B2563F47-E318-4EA4-A4BF-D65E7C99A21D @default.
- Q92578912 P478 Q92578912-6EDF8BC0-94FE-4D59-BC70-7B8E8A756B15 @default.
- Q92578912 P50 Q92578912-8B459E04-32AD-49C8-9C35-CF8D1FACD2C1 @default.
- Q92578912 P577 Q92578912-4E2A6A9D-86FB-4FB6-9081-4D1F49B7A532 @default.
- Q92578912 P698 Q92578912-860D827A-BC39-47CE-800F-EE103EB6C8F3 @default.
- Q92578912 P921 Q92578912-BD82F56B-0FF6-40ED-8555-6D439208959E @default.
- Q92578912 P932 Q92578912-E4D84556-9DC7-430D-8594-5D5DF0D7CC70 @default.
- Q92578912 P356 IJCP.13480 @default.
- Q92578912 P698 31927774 @default.
- Q92578912 P1433 Q15758177 @default.
- Q92578912 P1476 "Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo-controlled study" @default.
- Q92578912 P2093 "Claus G Roehrborn" @default.
- Q92578912 P2093 "François Giuliano" @default.
- Q92578912 P2093 "Michael J Manyak" @default.
- Q92578912 P2093 "Raymond C Rosen" @default.
- Q92578912 P2093 "Timothy H Wilson" @default.
- Q92578912 P2093 "Zrinka Lulic" @default.
- Q92578912 P304 "e13480" @default.
- Q92578912 P31 Q13442814 @default.
- Q92578912 P356 "10.1111/IJCP.13480" @default.
- Q92578912 P433 "5" @default.
- Q92578912 P478 "74" @default.
- Q92578912 P50 Q89672702 @default.
- Q92578912 P577 "2020-02-11T00:00:00Z" @default.
- Q92578912 P698 "31927774" @default.
- Q92578912 P921 Q506659 @default.
- Q92578912 P932 "7187250" @default.